FDA Inspection
VitalantVitalant – FDA Inspection, May 3, 2010
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on May 3, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- May 3, 2010
- Product Type
- Biologics
View Company Profile
ID · 8860559c-f2e5-4e0d-b2a1-782db4013be7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 662820
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 2, 2026 | Not classified | Denver District Office | Blood and Blood Products |
| December 7, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 23, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 8, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1305116 - 2026-03-02
- FDA Inspection 1194288 - 2022-12-07
- FDA Inspection 1075127 - 2018-10-23
- FDA Inspection 998084 - 2016-12-08
- FDA Inspection 913511 - 2015-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.